BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to HCC1806 cell line is 36
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MYC | 7553 | LTM | Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | Western Blotting followed by SFA and IF staining | NA | 0.52 | 0.1304 | 34889737 |
| MYC | 7553 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | Western Blotting and SFA | NA | 0.52 | 0.1304 | 35504883 |
| MYC | 7553 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by PCR array assay | NA | 0.52 | 0.1304 | 33510281 |
| NANOG | 20857 | LTM | Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | Western Blotting followed by SFA and IF staining | NA | 0.52 | 0.5461 | 34889737 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | Western Blotting followed by SFA | NA | 0.52 | 0.5461 | 29679903 |
| POU5F1 | 9221 | LTM | Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | Western Blotting followed by SFA and IF staining | NA | 0.52 | 0.6448 | 34889737 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | Western Blotting and SFA | NA | 0.52 | 0.6448 | 35504883 |
| GABRP | 4089 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0032 | 34023418 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs followed by SFA and IF staining | NA | 0.36 | 1 | 31612865 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by qRT-PCR and FACs | NA | 0.36 | 1 | 34023418 |
| CD44 | 1681 | LTM | Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by FACs | NA | 0.36 | 1 | 34889737 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs followed by SFA | NA | 0.36 | 1 | 34718356 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs followed by SFA | NA | 0.36 | 1 | 35504883 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by FACs | NA | 0.36 | 1 | 33672732 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs | NA | 0.36 | 1 | 29679903 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs | NA | 0.36 | 1 | 30091683 |
| KLF4 | 6348 | LTM | Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0891 | 34889737 |
| KLF4 | 6348 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs | NA | 0.28 | 0.0891 | 30091683 |
| SOX9 | 11204 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | Western Blotting and SFA | NA | 0.28 | 0.0244 | 35504883 |
| SOX2 | 11195 | LTM | Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | IF staining followed by SFA | NA | 0.24 | 0.5695 | 34889737 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.684 | 34023418 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | ALDEFLUOR assay followed by SFA | NA | 0.2 | 0.684 | 34718356 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | ALDEFLUOR assay followed by SFA | NA | 0.2 | 0.684 | 35504883 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by ALDEFLUOR assay | NA | 0.2 | 0.684 | 33510281 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by FACs | NA | 0.2 | 0.684 | 33672732 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | ALDEFLUOR assay | NA | 0.2 | 0.684 | 30091683 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 34718356 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 35504883 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by FACs | NA | 0.12 | 0.456 | 33672732 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by FACs | NA | 0.12 | 0.456 | 34023418 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs | NA | 0.12 | 0.456 | 29679903 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs | NA | 0.12 | 0.456 | 30091683 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 31612865 |
| ITGA6 | 6142 | LTM | Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by FACs | NA | 0.12 | 0.0265 | 34889737 |
| ITGA6 | 6142 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by FACs | NA | 0.12 | 0.0265 | 33672732 |
| ITGA6 | 6142 | LTM | Triple Negative Breast Cancer | Squamous Cell Carcinoma | HCC1806 | NA | SFA followed by PCR array assay | NA | 0.12 | 0.0265 | 33510281 |